Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome

Clinical Infectious Diseases

Volumn 39, Issue 7, 2004, Pages 1071-1075

  Wang, Wei Kung ^a,b   Chen, Shey Ying ^b   Liu, I Jung ^a   Kao, Chuan Liang ^a   Chen, Hui Ling ^a   Chiang, Bor Liang ^b   Wang, Jann Tay ^b   Sheng, Wang Hwei ^b   Hsueh, Po Ren ^b   Yang, Chao Fu ^a   Yang, Pan Chyr ^b   Chang, Shan Chwen ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; RIBAVIRIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DRUG EFFICACY; FEMALE; HUMAN; LUNG INFILTRATE; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTIVIRAL AGENTS; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; RIBAVIRIN; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TIME FACTORS; VIRAL LOAD;

EID: 4744370932     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/423808     Document Type: Article

References (16)

1. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. 26 September 2003. Available at: http://www.who.int/csr/sars/country/2003_09_26/en/. Accessed 26 December 2003.
2. Peiris JS, Yuen KY, Osterhaus AD, Stohr K. The severe acute respiratory syndrome. N Engl J Med 2003; 349:2431-41.
3. Ksiazek TG, Erdman D, Goldsmith C, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348:1953-66.
4. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348:1967-76.
5. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348:1986-94.
6. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in greater Toronto area. JAMA 2003; 289:2801-9.
7. Peiris JSM, Chu CH, Cheng VCC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003; 361:1767-72.
8. Nicholls JM, Poon LLM, Lee KC, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003; 361:1773-8.
9. Wang WK, Chen SY, Liu IJ, et al. Detection of large amount of SARS-associated coronavirus in throat wash and saliva: implications for transmission and early diagnosis. Emerg Infect Dis 2004; 10:1213-9.
10. World Health Organization. Case definitions for surveillance of SARS. Geneva: 1 May 2003. Available at: http://www.who.int/csr/sars/casedefinition/en/ . Accessed on 26 December 2003.
11. Wang JT, Sheng WH, Fang CT, et al. Clinical manifestations, laboratory findings and treatment outcomes of SARS patients. Emerg Infect Dis 2004; 10:818-24.
12. U. S. Centers for Disease Control and Prevention. Interim domestic infection control precautions for aerosol-generating procedures on patients with severe acute respiratory syndrome (SARS). 20 May 2003. Available at: http://www.cdc.gov/ncidod/sars/aerosolin fectioncontrol.htm. Accessed on 4 October 2003.
13. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 2003; 361: 2045-6.
14. Wong RSM, Wu A, To KF, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 2003; 326:1358-62.
15. Hsueh PR, Hsiao SH, Yeh SH, et al. Microbiologic characterization, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerg Infect Dis 2003; 9:1163-7.
16. Soo YO, Cheng Y, Wong R, et al. Retrospective comparison of covalescent plasma with continuing high dose of methylprednisolone treatment in SARS patients. Clin Microbiol Infect 2004; 10:678-8.